Showing results (121-130 of 349) with videos related to
Sort By:
Pageof 35
Clinical Nephrology|January 8, 2019
Telavancin-associated acute kidney injury
Corey Cavanaugh, Gilbert W Moeckel, Mark A PerazellaClinical Nephrology|November 23, 2017
Atypical case of classical polyarteritis nodosa: alveolar hemorrhage and positive antineutrophil cytoplasmic antibody
Nicole A Sitkin, Ethan Bernstein, Mark A PerazellaCurrent Opinion in Critical Care|September 28, 2017
Acute kidney injury and electrolyte disorders in the critically ill patient with cancerMitchell H Rosner, Giovambattista Capasso, Mark A PerazellaNature Reviews. Nephrology|July 18, 2018
Cardiorenal complications of immune checkpoint inhibitorsKrishna Sury, Mark A Perazella, Anushree C ShiraliAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2002
Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosisLes Lockridge, Rose J Papac, Mark A PerazellaClinical Journal of the American Society of Nephrology : CJASN|May 31, 2014
American Society of Nephrology Quiz and Questionnaire 2013: RRTRajnish Mehrotra, Mark A Perazella, Michael J ChoiAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 20, 2024
Toxic Nephropathies of the Tubulointerstitium: Core Curriculum 2024Namrata Krishnan, Dennis G Moledina, Mark A PerazellaThe American Journal of the Medical Sciences|July 11, 2009
A case of extreme hemodynamic lability and hypocalcemiaFelix Knauf, Gary V Desir, Mark A PerazellaAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 22, 2008
Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfateDeepak Kadiyala, David A Roer, Mark A PerazellaKidney International|June 1, 2012
Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis?Jonathan Hogan, Michael H Schwenk, Jai RadhakrishnanPageof 35